At any rate, the race is on for Vanadium. The supplies are tighter than uranium at the moment, and that is saying something. I believe it is the "tightest" mineral in the supply chain.
It seems to me that this area is RIPE for equity for tech deals (like Go2Lithium only involving Vanadium). Perhaps the newest subsidiary (partnership): Future Element Joint Venture has the greatest potential benefit.
https://www.cleanteqwater.com/news/future-element-jv-established-to-accelerate-expansion-into-global-mine-tailings-management/
This begs for future questions during the next publicly involved board meeting......
If any of you actually read this, and you happen to live in Australia, could you ask some Vanadium centric questions at the next public board meeting? It would be interesting to hear / read what Peters' response is.
- Forums
- ASX - By Stock
- CNQ
- Ann: CNQ enters Nth American lithium market tech-for-equity deal
Ann: CNQ enters Nth American lithium market tech-for-equity deal, page-61
-
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CNQ (ASX) to my watchlist
|
|||||
Last
29.0¢ |
Change
-0.015(4.92%) |
Mkt cap ! $20.19M |
Open | High | Low | Value | Volume |
28.5¢ | 29.0¢ | 28.5¢ | $28.28K | 99.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10560 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 8685 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10560 | 0.290 |
4 | 19000 | 0.280 |
1 | 37300 | 0.275 |
1 | 15000 | 0.270 |
1 | 30000 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 8685 | 1 |
0.310 | 100 | 1 |
0.320 | 76599 | 3 |
0.330 | 150000 | 1 |
0.345 | 10000 | 1 |
Last trade - 15.58pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
CNQ (ASX) Chart |